Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1991-5-3
|
pubmed:abstractText |
Case reports have prompted concern that the use of bromocriptine mesylate to prevent lactation in the puerperium increases the risk of postpartum seizure. We conducted a record-based case-control study of postpartum seizures in three data bases to evaluate this relation. We identified 43 women who had a postpartum seizure, and we matched 319 controls individually by hospital of delivery, quinquenium of age, and time of delivery. Overall, women taking bromocriptine had a 22% lower risk for seizures, that is, the relative risk estimate was 0.78, with a 90% confidence interval of 0.29 to 1.87. A reduction in seizure risk is consistent with reports of antiseizure activity for bromocriptine in various species, including humans. We found a small positive association between bromocriptine use and seizures occurring more than 72 hours after delivery, with a relative risk estimate of 1.6 after controlling for seizure history. This association was offset by a strong negative association between bromocriptine use and early-occurring seizures. The pattern of an initial reduced risk followed by an increase to normal or above-normal levels of risk could result from an antiseizure activity of bromocriptine, with a rebound in risk when bromocriptine is withdrawn.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1044-3983
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
232-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2081258-Adolescent,
pubmed-meshheading:2081258-Adult,
pubmed-meshheading:2081258-Bromocriptine,
pubmed-meshheading:2081258-Case-Control Studies,
pubmed-meshheading:2081258-Confidence Intervals,
pubmed-meshheading:2081258-Drug Interactions,
pubmed-meshheading:2081258-Ergonovine,
pubmed-meshheading:2081258-Female,
pubmed-meshheading:2081258-Humans,
pubmed-meshheading:2081258-Lactation,
pubmed-meshheading:2081258-Puerperal Disorders,
pubmed-meshheading:2081258-Risk,
pubmed-meshheading:2081258-Seizures,
pubmed-meshheading:2081258-Time Factors
|
pubmed:year |
1990
|
pubmed:articleTitle |
Bromocriptine and puerperal seizures.
|
pubmed:affiliation |
Epidemiology Resources Inc, Chestnut Hill, MA 02167.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|